Tech Company Financing Transactions
ActX Funding Round
Private investors participated in a $1.2 million capital raise for ActX. The financing round was announced by the company on 7/17/2017.
Transaction Overview
Company Name
Announced On
7/17/2017
Transaction Type
Venture Equity
Amount
$1,209,785
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 37 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1100 Dexter Ave. North 100
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Website
Email Address
Not Recorded
Overview
ActX makes using genetics practical for physicians and patients. Focus on risks that you can do something about. Begin the era of precision medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Ury
VP - Bus. Development
Stephen Scheer
Browse more venture capital transactions:
Prev: 7/17/2017: theMednet venture capital transaction
Next: 7/17/2017: Fresh Nation venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs